세계의 셀소팅 시장 규모 : 제품 및 서비스별, 기술별, 최종사용자별, 지역별, 범위 및 예측

Cell Sorting Market Size And Forecast

Cell Sorting Market Size was valued at USD 259.83 Million in 2023 and is projected to reach USD 440.13 Million by 2031, growing at a CAGR of 6.81% from 2024 to 2031. Cell sorting is a complex laboratory technique that separates and isolates specific types of cells from a mixed population depending on their physical and biochemical properties. This method is critical for a variety of applications including biological research, clinical diagnostics, and pharmaceutical development. It is critical in a variety of applications, greatly advancing research and therapeutic practices. In fundamental research, cell sorting is used to isolate certain cell populations from heterogeneous materials allowing scientists to explore cellular mechanisms, gene expression, and cell activity in depth.

Cell sorting technology is projected to play an increasingly important role in personalized medicine and enhanced therapeutic techniques. Future cell sorters will provide higher resolution, faster processing rates, and greater precision as microfluidics and automation progress. This will improve skills in areas like single-cell analysis where knowing the heterogeneity of individual cells can lead to more effective and personalized treatments.

Global Cell Sorting Market Dynamics

The key market dynamics that are shaping the global Cell Sorting Market include:

Key Market Drivers:

Advances in Biotechnology and Genomics

: The rapid advancement of biotechnology and genomics is a major driver of the Cell Sorting Market. Single-cell genomics and proteomics are techniques that need exact cell separation to evaluate gene expression, genetic variants, and protein interactions at the individual cell level.

Growing Focus on Personalized Medicine:

The growing focus on personalized medicine and tailored therapeutics is having a substantial impact on the cell sorting business. Personalized medicine is based on understanding individual patients' genetic and molecular profiles to better personalize treatments.

Increase in Cancer Research and Immunotherapy

: Increased emphasis on cancer research and immunotherapy is a major market driver. The expansion of cancer research programs as well as the increasing number of clinical trials focusing on immunotherapy and cell-based treatments creates a strong demand for cell-sorting technologies capable of supporting these complicated and high-throughput applications.

Key Challenges:

Sample Preparation and Quality:

Successful cell sorting is dependent on high-quality sample preparation. Poorly prepared samples can result in incorrect sorting and compromised results. Cell aggregation, debris, and sample volume discrepancies can all have an impact on how efficiently and accurately the sorting process works. Maintaining consistent and high-quality sample preparation is a considerable task.

Data Management and Analysis:

Cell sorting generates large volumes of data that must be handled and examined. This requires not only sorting data but also interpreting the ensuing biological data to draw relevant conclusions. Handling and analyzing this data can be difficult necessitating advanced software and processing resources.

Advancements in Biotechnology and Genomics:

Rapid advances in biotechnology and genetics are a key driver of the Cell Sorting Market. The growing requirement for precise cell analysis and separation in research and clinical settings is driving up demand for sophisticated cell sorting technologies. Techniques such as single-cell genomics and transcriptomics necessitate high-resolution cell sorting to provide detailed insights into cellular activities and diversity.

Key Trends:

Cell Sorter Technology Advancements:

Innovations in cell sorter technology are propelling the market forward. Modern cell sorters now have advanced features such as high-speed sorting, increased sensitivity, and multi-parameter analysis. Microfluidic-based sorters and digital droplet sorting are transforming the discipline by enabling more precise and efficient separation of complicated cell populations.

Increased Demand for Personalized Medicine:

The push for personalized medicine has a substantial impact on the Cell Sorting Market. Cell sorting is critical for finding biomarkers and understanding disease mechanisms at the cellular level both of which are necessary for the development of customized therapeutics.

Rising Applications in Stem Cell Research

: Stem cell research is a significant driver of growth in the Cell Sorting Market. The ability to accurately sort and purify stem cells is essential for understanding their biology and creating stem cell-based therapeutics. As regenerative medicine improves, sophisticated cell sorting technologies to isolate and evaluate stem cells become increasingly important.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cell Sorting Market Regional Analysis

Here is a more detailed regional analysis of the global Cell Sorting Market:

North America:

The North American region dominates the global Cell Sorting Market owing mostly to significant investments in R&D and a strong healthcare infrastructure. This dominance is strengthened by the presence of large industry companies and sophisticated technological skills in the region. Significant funding for life sciences research is a key driver of the North American Cell Sorting Market.

According to the National Institutes of Health (NIH), the world's largest public supporter of biomedical research, the budget for fiscal year 2023 is USD 47.5 Billion, up USD 2.5 Billion from 2022. This large grant directly supports research initiatives that use cell sorting methods. The California Institute for Regenerative Medicine (CIRM), the largest state-funded stem cell organization in the United States, has provided over USD 2.9 Billion in grants since its founding, promoting research that mainly relies on cell sorting technology.

Furthermore, the Alliance for Regenerative Medicine reports that as of 2021, there were over 1,085 regenerative medicine enterprises worldwide, with a sizable proportion situated in North America. This concentration of research and development activities in regenerative medicine and stem cell therapies drives demand for improved cell sorting solutions in the region cementing North America's dominance in the worldwide Cell Sorting Market.

Asia Pacific:

The Asia Pacific region is having the highest growth in the Cell Sorting Market owing mostly to rapid advances in biotechnology and increased spending in healthcare research & development. Countries such as China, Japan, and India have exceptionally rapid growth. The rising frequency of chronic diseases as well as the resulting demand for enhanced diagnosis and treatment approaches are significant drivers of the Cell Sorting Market in Asia Pacific.

According to the World Health Organization (WHO), noncommunicable illnesses cause 71% of all deaths worldwide with Asia Pacific countries bearing a disproportionate burden. According to China's National Cancer Center, 10.7 million new cancer cases were reported in 2020. This high illness burden is driving investments in cell-based research and therapeutics resulting in increased demand for cell-sorting technology.

Global Cell Sorting Market: Segmentation Analysis

The Global Cell Sorting Market is segmented based on Product and Services, Technology, End-Users, and Geography.

Cell Sorting Market, By Product and Services

• Cell Sorting Reagents and Consumables
• Cell Sorting Services
• Cell Sorters

Based on Products and Services, the Global Cell Sorting Market is bifurcated into Cell Sorting Reagents and Consumables, Cell Sorting Services, and Cell Sorters. In the global Cell Sorting Market, cell sorters are the dominant product and service segment. This dominance is due to the essential role cell sorters play in enabling researchers and clinicians to separate and analyze specific cell populations with high precision. Advances in technology have led to the development of more sophisticated cell sorters offering improved accuracy, speed, and functionality which are critical for applications in research, diagnostics, and therapeutic development.

Cell Sorting Market, By Technology

• Fluorescence-Based Droplet Cell Sorting
• Jet-In-Air Cell Sorting
• Cuvette-Based Cell Sorting
• Magnetic-Activated Cell Sorting (MACS)
• Micro-Electromechanical Systems (MEMS) - Microfluidics

Based on Technology, the Global Cell Sorting Market is bifurcated into Fluorescence-Based Droplet Cell Sorting, Jet-In-Air Cell Sorting, Cuvette-Based Cell Sorting, Magnetic-Activated Cell Sorting (MACS), and Micro-Electromechanical Systems (MEMS) - Microfluidics. In the global Cell Sorting Market, fluorescence-based droplet cell sorting is the dominant technology. This dominance is attributed to its high efficiency and precision in separating cells based on fluorescence markers. Fluorescence-based systems can analyze multiple parameters simultaneously allowing for detailed cell characterization and sorting with high purity. This technology is widely used in research, clinical diagnostics, and drug development due to its ability to handle complex samples and provide high-resolution results.

Cell Sorting Market, By End-Users

• Research Institutions
• Medical Schools and Academic Institutions
• Pharmaceutical and Biotechnology Companies
• Hospitals and Clinical Testing Laboratories

Based on End-Users, the Global Cell Sorting Market is bifurcated into Research Institutions, Medical Schools and Academic Institutions, Pharmaceutical and Biotechnology Companies, and Hospitals and Clinical Testing Laboratories. Pharmaceutical and biotechnology companies are the dominant end-users in the global Cell Sorting Market. This dominance stems from the crucial role cell sorting plays in drug development, personalized medicine, and cellular therapies. These companies utilize cell sorting technology to isolate and analyze specific cell populations which is essential for developing targeted therapies and understanding disease mechanisms.

Cell Sorting Market, By Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Rest of the World

Based on Geography, the Global Cell Sorting Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and the Rest of the World. North America is the dominant region in the global Cell Sorting Market. This dominance is attributed to the region's advanced healthcare infrastructure, significant investment in research and development, and high adoption rates of cutting-edge technologies. North America, particularly the United States, hosts numerous leading biotechnology firms, academic institutions, and research organizations that drive demand for advanced cell sorting technologies.

Key Players

• The "Global Cell Sorting Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Becton, Dickinson and Company, Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc., Sony Biotechnology, Inc. (A Wholly Owned Subsidiary of Sony Corporation of America), MiltenyiBiotec GmbH, Affymetrix, Inc. (A Thermo Fisher Scientific Company), SysmexPartec GmbH (A Subsidiary of Sysmex Corporation), On-Chip Biotechnologies Co., Ltd., Cytonome/St, LLC, Union Biometrica, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Cell Sorting Market Key Developments

• In May 2023, BD, a medical technology company, introduced new cell sorting equipment with two revolutionary technologies. This allows scientists to find comprehensive information about cells that were previously invisible in typical flow cytometry research.
• In January 2023, Thermo Fisher Scientific announced that the Bigfoot Spectral Cell Sorter would be available in India. The first-of-its-kind cell sorting Technology combines traditional sorting with spectral sorting and analysis to give simple, high-speed cell sorting.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CELL SORTING MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL CELL SORTING MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL CELL SORTING MARKET, BY PRODUCT AND SERVICES

• 5.1 Overview
• 5.2 Cell Sorting Reagents and Consumables
• 5.3 Cell Sorting Services
• 5.4 Cell Sorters

6 GLOBAL CELL SORTING MARKET, BY TECHNOLOGY

• 6.1 Overview
• 6.2 Fluorescence-Based Droplet Cell Sorting
• 6.3 Jet-In-Air Cell Sorting
• 6.4 Cuvette-Based Cell Sorting
• 6.5 Magnetic-Activated Cell Sorting (MACS)
• 6.6 Micro-Electromechanical Systems (MEMS) - Microfluidics

7 GLOBAL CELL SORTING MARKET, BY END USER

• 7.1 Overview
• 7.2 Research Institutions
• 7.3 Medical Schools and Academic Institutions
• 7.4 Pharmaceutical and Biotechnology Companies
• 7.5 Hospitals and Clinical Testing Laboratories

8.GLOBAL CELL SORTING MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL CELL SORTING MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Becton, Dickinson and Company
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Bio-Rad Laboratories, Inc.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Sony Biotechnology Inc. (A Wholly Owned Subsidiary of Sony Corporation of America)
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 MiltenyiBiotec GmbH
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Affymetrix, Inc. (A Thermo Fisher Scientific Company)
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 SysmexPartec GmbH (A Subsidiary of Sysmex Corporation)
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 On-Chip Biotechnologies Co., Ltd.
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Cytonome/St, LLC
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Union Biometrica, Inc
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research